51 Prevalence of Clostridioides difficile in people with cystic fibrosis participating in the PROMISE Study before and after initiating elexacaftor/tezacaftor/ivacaftor.

Autor: Gill, E. (AUTHOR), Duong, J. (AUTHOR), Pope, C. (AUTHOR), Hayden, H. (AUTHOR), Verster, A. (AUTHOR), Hoffman, L. (AUTHOR), Schwarzenberg, S. (AUTHOR), Heltshe, S. (AUTHOR), Solomon, G. (AUTHOR), Freedman, S. (AUTHOR), Goss, C. (AUTHOR)
Zdroj: Journal of Cystic Fibrosis. Sep2024 Supplement 2, Vol. 23, pS27-S28. 2p.
Databáze: Academic Search Ultimate
Externí odkaz: